Showing 1 - 20 results of 35 for search 'Igor V Maev', query time: 4.68s
Refine Results
-
1
-
2
-
3
Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis by Vasiliy I. Reshetnyak, Igor V. Maev
Published 2022-11-01
Article -
4
Drug-induced liver injury: diagnosis of exclusion by Igor V. Maev, Tatiana E. Polunina
Published 2023-10-01
Article -
5
-
6
The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review by Dmitry N. Andreev, Igor V. Maev
Published 2023-08-01
Article -
7
Role of Mutations in NOD2/CARD15, ATG16L1, and IRGM in the Pathogenesis of Crohn’s Disease by Igor’ V. Maev, Dmitry N. Andreev
Published 2014-03-01
Article -
8
-
9
Metabolically associated fatty liver disease – a disease of the 21st century: A review by Igor V. Maev, Dmitry N. Andreev, Yury A. Kucheryavyy
Published 2022-07-01
Article -
10
Prevalence of non-alcoholic fat disease liver in Russian Federation: meta-analysis by Igor V. Maev, Dmitry N. Andreev, Yury A. Kucheryavyy
Published 2023-08-01
Article -
11
Current <i>Helicobacter pylori</i> Diagnostics by Dmitry S. Bordin, Irina N. Voynovan, Dmitrii N. Andreev, Igor V. Maev
Published 2021-08-01
Article -
12
-
13
-
14
-
15
Inflammatory bowel diseases: Transformation of representations. A review by Igor V. Maev, Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva
Published 2023-12-01
Article -
16
-
17
-
18
-
19
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria by Dmitry N. Andreev, Dmitry S. Bordin, Elena S. Vyuchnova, Ekaterina G. Lebedeva, Diana T. Dicheva, Renata M. Umyarova, Igor V. Maev
Published 2022-10-01
Article -
20
Effectiveness of Rebamipide as a part of the <i>Helicobacter pylori</i> eradication therapy in Russia: a meta-analysis of controlled trials by Dmitry N. Andreev, Igor V. Maev, Dmitry S. Bordin, Svetlana V. Lyamina, Diana T. Dicheva, Aleksei K. Fomenko, Armine S. Bagdasarian
Published 2022-07-01
Article